Clinical impact of myocardial mTORC1 activation in nonischemic dilated cardiomyopathy.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Journal of Molecular and Cellular Cardiology

• Publication date

  2016-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.yjmcc.2015.12.022PMID 26739211
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Altered signaling for mitochondrial and myofibrillar biogenesis in skeletal muscles of multiple sclerosis patients

  2015cited by this paper
• Altered signaling for mitochondrial and myofibrillar biogenesis in skeletal muscles of patients with multiple sclerosis.

  2015cited by this paper
• Everolimus-responsive dilated cardiomyopathy in tuberous sclerosis.

  2015cited by this paper
• Arrestin-dependent Angiotensin AT1 Receptor Signaling Regulates Akt and mTor-mediated Protein Synthesis*

  2014cited by this paper
• Metabolomic Analysis of Pressure-Overloaded and Infarcted Mouse Hearts

  2014cited by this paper
• Akt and mTOR mediate programmed necrosis in neurons

  2014cited by this paper
• Pivotal Role of mTORC2 and Involvement of Ribosomal Protein S6 in Cardioprotective Signaling

  2014cited by this paper
• Rapamycin nanoparticles target defective autophagy in muscular dystrophy to enhance both strength and cardiac function

  2014influential reference
• Pivotal Role of mTORC2 and Involvement of Ribosomal Protein S6 in Cardioprotective Signaling

  2014cited by this paper
• Heparin-Binding EGF-Like Growth Factor Induces Heart Interstitial Fibrosis via an Akt/mTor/p70s6k Pathway

  2012cited by this paper
• Temsirolimus Activates Autophagy and Ameliorates Cardiomyopathy Caused by Lamin A/C Gene Mutation

  2012cited by this paper
• mTORC1‐ and mTORC2‐interacting proteins keep their multifunctional partners focused

  2011cited by this paper
• Cardiac Raptor Ablation Impairs Adaptive Hypertrophy, Alters Metabolic Gene Expression, and Causes Heart Failure in Mice

  2011cited by this paper
• MTORC1 regulates cardiac function and myocyte survival through 4E-BP1 inhibition in mice.

  2010influential reference
• The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress

  2007influential reference
• Inhibition of mTOR Signaling With Rapamycin Regresses Established Cardiac Hypertrophy Induced by Pressure Overload

  2004cited by this paper
• Progression From Compensated Hypertrophy to Failure in the Pressure-Overloaded Human Heart: Structural Deterioration and Compensatory Mechanisms

  2003cited by this paper

• Intensity, Duration, and Context Dependency of the Responses to Nutrient Surplus and Deprivation Signaling in the Heart: Insights Into the Complexities of Cardioprotection

  2025cites this paper
• Allelic heterogeneity of TTNtv dilated cardiomyopathy can be modeled in adult zebrafish

  2024cites this paper
• Narrative Review of Immunomodulatory and Anti-inflammatory Effects of Sodium-Glucose Cotransporter 2 Inhibitors: Unveiling Novel Therapeutic Frontiers

  2024cites this paper
• Contribution of MLKL to the development of doxorubicin-induced cardiomyopathy and its amelioration by rapamycin.

  2024cites this paper
• SGLT2 inhibitors: role in protective reprogramming of cardiac nutrient transport and metabolism

  2023cites this paper
• Critical Reanalysis of the Mechanisms Underlying the Cardiorenal Benefits of SGLT2 Inhibitors and Reaffirmation of the Nutrient Deprivation Signaling/Autophagy Hypothesis

  2022cites this paper
• Enhanced nuclear localization of phosphorylated MLKL predicts adverse events in patients with dilated cardiomyopathy

  2022cites this paper
• Synergistic Combined-proteomics Guided Mapping strategy identifies mTOR mediated phosphorylation of LARP1 in nutrient responsiveness and dilated cardiomyopathy

  2022cites this paper
• Signaling network model of cardiomyocyte morphological changes in familial cardiomyopathy

  2021cites this paper
• Modifications of Titin Contribute to the Progression of Cardiomyopathy and Represent a Therapeutic Target for Treatment of Heart Failure

  2020cites this paper
• Molecular, Cellular, and Clinical Evidence That Sodium‐Glucose Cotransporter 2 Inhibitors Act as Neurohormonal Antagonists When Used for the Treatment of Chronic Heart Failure

  2020cites this paper
• Longevity genes, cardiac ageing, and the pathogenesis of cardiomyopathy: implications for understanding the effects of current and future treatments for heart failure

  2020cites this paper
• The Giant Protein Titin’s Role in Cardiomyopathy: Genetic, Transcriptional, and Post-translational Modifications of TTN and Their Contribution to Cardiac Disease

  2019cites this paper
• Titin mutations and muscle disease

  2019cites this paper
• Therapeutic Potential of Oxytocin in Atherosclerotic Cardiovascular Disease: Mechanisms and Signaling Pathways

  2019influential citation
• The Translational Landscape of the Human Heart.

  2019cites this paper
• Covalent Targeting of the Vacuolar H+-ATPase Activates Autophagy Via mTORC1 Inhibition

  2019cites this paper
• Role of titin in cardiomyopathy: from DNA variants to patient stratification

  2018cites this paper
• Analysis of the Correlation between the Myocardial Expression of DPP-4 and the Clinical Parameters of Patients with Heart Failure.

  2018cites this paper
• New Insights Into the Role of mTOR Signaling in the Cardiovascular System.

  2018cites this paper
• Pathological basis of cardiac arrhythmias: vicious cycle of immune-metabolic dysregulation

  2017cites this paper
• Research January 20 , 2017 Pyruvate Kinase M 2 — Footprints of the Warburg Effect in the Heart ?

  2017cites this paper
• Oncometabolic Tracks in the Heart

  2017cites this paper
• Titin truncating variants affect heart function in disease cohorts and the general population

  2016cites this paper
• Tanshinon II A attenuates diabetic cardiomyopathy by down-regulation of mTOR / P 70 S 6 K signaling pathway

  2016cites this paper
• De novo RRAGC mutation activates mTORC1 signaling in syndromic fetal dilated cardiomyopathy

  2016cites this paper